Clinical trial
Study of Ambrisentan in Participants With Pulmonary Hypertension
NCT00777920
Study timeline
Study start (actual)2008-11-17Date precision: day
Registry last updated2020-09-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Hypertensionunresolved
Interventions
AmbrisentanDRUG · verified · RxNorm: ambrisentan
Sponsors & collaborators
Gilead Scienceslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00777920 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.